The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of critical care

• Publication date

  2017-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jcrc.2017.03.008PMID 28319910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock

  2018influential reference
• Early goal-directed therapy in the treatment of severe sepsis and septic shock.

  2018cited by this paper
• Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

  2017cited by this paper
• Selepressin and Arginine Vasopressin Do Not Display Cardiovascular Risk in Atherosclerotic Rabbit

  2016cited by this paper
• Heart rate reduction with esmolol is associated with improved arterial elastance in patients with septic shock: a prospective observational study

  2016cited by this paper
• Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.

  2016cited by this paper
• A new frontier for an old drug? A word of caution for beta-blockers in sepsis!

  2015cited by this paper
• Oxytocin, Vasopressin, and the Motivational Forces that Drive Social Behaviors.

  2015cited by this paper
• Critical care evidence--new directions.

  2015cited by this paper
• A Selective V1A Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock*

  2015cited by this paper
• Diastolic dysfunction and mortality in septic patients: a systematic review and meta-analysis

  2015cited by this paper
• What’s new in vasopressin?

  2015cited by this paper
• The Selective Vasopressin Type 1a Receptor Agonist Selepressin (FE 202158) Blocks Vascular Leak in Ovine Severe Sepsis*

  2014cited by this paper
• Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis

  2013cited by this paper
• Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.

  2013cited by this paper
• Circulatory shock.

  2013cited by this paper
• Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor*

  2012cited by this paper
• Nationwide Trends of Severe Sepsis in the 21st Century (2000-2007)

  2012cited by this paper
• Abstracts of the 42nd Critical Care Congress. January 19-23, 2013. San Juan, Puerto Rico.

  2012cited by this paper
• Physician Referral Rather than Proxy Referral to an Organ Procurement Organization Following Asystolic Death Results in Higher Tissue Donation Rates

  2012cited by this paper
• Nationwide trends of severe sepsis in the 21st century (2000-2007).

  2011cited by this paper
• Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality*

  2011cited by this paper
• Vasopressin analogues and V1a receptor agonists in septic shock

  2011cited by this paper
• New, potent, selective, and short-acting peptidic V1a receptor agonists.

  2011cited by this paper
• Pharmacological Characterization of FE 202158, a Novel, Potent, Selective, and Short-Acting Peptidic Vasopressin V1a Receptor Full Agonist for the Treatment of Vasodilatory Hypotension

  2011cited by this paper
• Best vasopressor for advanced vasodilatory shock: should vasopressin be part of the mix?

  2010cited by this paper
• Comparison of dopamine and norepinephrine in the treatment of shock.

  2010cited by this paper
• The effects of vasopressin on acute kidney injury in septic shock

  2009cited by this paper
• Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study

  2009cited by this paper
• Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock*

  2009cited by this paper
• Vasopressin plus corticosteroids: the shock duo!

  2009cited by this paper
• Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice

  2009cited by this paper
• The vasopressin and copeptin response to infection, severe sepsis, and septic shock*

  2009cited by this paper
• Contractile response of norepinephrine is modulated by caspase-3 in adult rat ventricular myocytes isolated from septic rat heart.

  2009cited by this paper
• P2X receptors are differentially expressed on vasopressin- and oxytocin-containing neurons in the supraoptic and paraventricular nuclei of rat hypothalamus

  2008cited by this paper
• A comparison of epinephrine and norepinephrine in critically ill patients

  2008cited by this paper
• Physiology of the vasopressin receptors.

  2008cited by this paper
• Vasopressin versus norepinephrine infusion in patients with septic shock.

  2008cited by this paper
• Long-term outcomes from sepsis

  2007cited by this paper
• Endogenous and exogenous vasopressin in shock

  2007cited by this paper
• METHYLPREDNISOLONE REVERSES VASOPRESSIN HYPORESPONSIVENESS IN OVINE ENDOTOXEMIA

  2007cited by this paper
• Vasopressin in vasodilatory and septic shock

  2007cited by this paper
• Glucose metabolism and catecholamines

  2007cited by this paper
• Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

  2007cited by this paper
• Vasopressin: Mechanisms of action on the vasculature in health and in septic shock

  2007cited by this paper
• Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.

  2007cited by this paper
• Vasopressin-induced nitric oxide production in rat inner medullary collecting duct is dependent on V2 receptor activation of the phosphoinositide pathway.

  2007cited by this paper
• Vasopressin in septic shock

  2007cited by this paper
• Neuroanesthesia and Intensive Care Review article: Organ perfusion/permeability- related effects of norepinephrine and vasopressin

  2006cited by this paper
• Are the effects of noradrenaline, adrenaline and dopamine infusions on $$\dot VO_2 $$ and metabolism transient?and metabolism transient?

  2006cited by this paper
• Review article: Organ per fusion/permeabilityrelated effects of norepinephrine and vasopressin in sepsis

  2006cited by this paper
• Epidemiology of severe sepsis around the world.

  2006cited by this paper
• Sepsis in European intensive care units: Results of the SOAP study*

  2006cited by this paper
• Adrenergic modulation of cytokine release in bone marrow progenitor-derived macrophage following polymicrobial sepsis.

  2005cited by this paper
• Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: Effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism*

  2005cited by this paper
• The central vasopressinergic system: examining the opportunities for psychiatric drug development.

  2005cited by this paper
• Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.

  2004cited by this paper
• Circulating vasopressin levels in septic shock.

  2003cited by this paper
• Effect of arginine vasopressin on the canine epicardial coronary artery: experiments on V1-receptor-mediated production of nitric oxide.

  2003cited by this paper
• Science Review: Vasopressin and the cardiovascular system part 1 – receptor physiology

  2003cited by this paper
• Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)

  2003cited by this paper
• Efeito da vasopressina em artérias coronárias epicárdicas caninas: experimentos sobre a produção do óxido nítrico mediate a estimulação de receptores

  2003cited by this paper
• Depletion of neurohypophyseal content of vasopressin in septic shock.

  2002cited by this paper
• Early goal-directed therapy in the treatment of severe sepsis and septic shock

  2002cited by this paper
• Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

  2001cited by this paper
• Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin.

  2001cited by this paper
• Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.

  2000cited by this paper
• Oxytocin is a cardiovascular hormone.

  2000cited by this paper
• Human vascular endothelial cells express oxytocin receptors.

  1999cited by this paper
• Structural bases of vasopressin/oxytocin receptor function.

  1998cited by this paper
• Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats.

  1998cited by this paper
• Vasopressin receptors. A historical survey.

  1998cited by this paper
• Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock

  1998cited by this paper
• Effects of F‐180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension

  1998cited by this paper
• Arginine vasopressin-mediated stimulation of nitric oxide within the rat renal medulla.

  1998cited by this paper
• Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin.

  1997cited by this paper
• Vasopressin deficiency contributes to the vasodilation of septic shock.

  1997cited by this paper
• Regulation of aquaporin-2 water channel trafficking by vasopressin.

  1997cited by this paper
• Are the effects of noradrenaline, adrenaline and dopamine infusions on VO2 and metabolism transient?

  1995cited by this paper
• Comparison of responses of canine pulmonary artery and vein to angiotensin II, bradykinin and vasopressin.

  1995cited by this paper
• Molecular pharmacology of V1a vasopressin receptors.

  1995cited by this paper
• Antidiuretic effects of ATP induced by microinjection into the hypothalamic supraoptic nucleus in water-loaded and ethanol-anesthetized rats.

  1994cited by this paper
• Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

  1992cited by this paper
• Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor.

  1984cited by this paper
• Osmotic and nonosmotic control of vasopressin release.

  1979cited by this paper

• Review of research progress in sepsis-associated acute kidney injury

  2025cites this paper
• Sepsis in Pregnancy: Exploring Recent Advances in Diagnosis and Management

  2025influential citation
• A Guide to the Use of Vasopressors and Inotropes for Patients in Shock

  2024cites this paper
• Effects of Terlipressin on Management of Hypotensive Brain-Dead Patients Who are Potential Organ Donors: A Retrospective Study

  2021cites this paper
• Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective

  2021cites this paper
• Clinical Update on Vasopressors and Titration Strategies.

  2021cites this paper
• Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis

  2020cites this paper
• Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin

  2020cites this paper
• Non-catecholamine vasopressors in the treatment of adult patients with septic shock—evidence from meta-analysis and trial sequential analysis of randomized clinical trials

  2020cites this paper
• Case report on intravenous octreotide for the treatment of intraoperative vasoplegia following thymoma resection

  2019cites this paper
• Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial.

  2019cites this paper
• The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis

  2019cites this paper
• Review article: Sepsis in the emergency department – Part 3: Treatment

  2018cites this paper
• Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical Trial.

  2018cites this paper
• Role of vasopressin in current anesthetic practice

  2017cites this paper
• Vitamin C in sepsis

  2017cites this paper